Enoxaparin versus tinzaparin in non-ST-segment elevation acute coronary syndromes: results of the enoxaparin versus tinzaparin (EVET) trial at 6 months. - Katsouras, C; Michalis, LK; Papamichael, N (Am Heart J, 2005)
et al.